ConductScience.org, home

Paper39405607

Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.

Qin R and 11 others. Transl Oncol, 2024. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance. Papers, record 39405607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39405607

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.
PubMed
Journal
Transl Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
4.71, provisional
iCite
Revised in PubMed
2025-01-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qin RRong
2Fan XXirui
3Huang YYun
4Chen SSijing
5Ding RRui
6Yao YYing
7Wu RRui
8Duan YYiyao
9Li XXiang
10Khan HUHameed Ullah
11Hu JJun
12Wang HHui

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122228080Metabolic symbiosis in cancer: refocusing the Warburg lens.Mol Carcinog2013https://conductscience.org/library/papers/22228080PubMed
233244454Thrombospondin 2/Toll-Like Receptor 4 Axis Contributes to HIF-1α-Derived Glycolysis in Colorectal Cancer.Front Oncol2020https://conductscience.org/library/papers/33244454PubMed
333546704The cancer metabolic reprogramming and immune response.Mol Cancer2021https://conductscience.org/library/papers/33546704PubMed
436232922Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p.Int J Mol Sci2022https://conductscience.org/library/papers/36232922PubMed
537597817The interaction between apigenin and PKM2 restrains progression of colorectal cancer.J Nutr Biochem2023https://conductscience.org/library/papers/37597817PubMed
636200045Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.Front Cell Dev Biol2022https://conductscience.org/library/papers/36200045PubMed
730926638RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer.Mol Cancer Ther2019https://conductscience.org/library/papers/30926638PubMed
835288533An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.Cell Death Dis2022https://conductscience.org/library/papers/35288533PubMed
935441953Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.Biochem Genet2022https://conductscience.org/library/papers/35441953PubMed
1031375671LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.Nat Commun2019https://conductscience.org/library/papers/31375671PubMed
1131781676PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling.J Immunol Res2019https://conductscience.org/library/papers/31781676PubMed
1228761044Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells.Sci Rep2017https://conductscience.org/library/papers/28761044PubMed
1327922662Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.Int J Oncol2017https://conductscience.org/library/papers/27922662PubMed
1436695827Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.Cancer Immunol Immunother2023https://conductscience.org/library/papers/36695827PubMed
1531803611The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism.Front Oncol2019https://conductscience.org/library/papers/31803611PubMed
1638414789ENO1 deletion potentiates ferroptosis and decreases glycolysis in colorectal cancer cells via AKT/STAT3 signaling.Exp Ther Med2024https://conductscience.org/library/papers/38414789PubMed
1738715141CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration.Biol Direct2024https://conductscience.org/library/papers/38715141PubMed
1830936746Oncogenic role of ABHD5 in endometrial cancer.Cancer Manag Res2019https://conductscience.org/library/papers/30936746PubMed
1936929658Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.Biofactors2023https://conductscience.org/library/papers/36929658PubMed
2032110048HNF1A-AS1 Regulates Cell Migration, Invasion and Glycolysis via Modulating miR-124/MYO6 in Colorectal Cancer Cells.Onco Targets Ther2020https://conductscience.org/library/papers/32110048PubMed

See all 127 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42979438Aspirin induces glycolytic reprogramming via lysine salicylation of ALDOA.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979438PubMed
42897352NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.J Mol Med (Berl)2026https://conductscience.org/library/papers/42897352PubMed
42758364Mitochondrial metabolite transporters at the crossroads of metabolic reprogramming, epigenetic regulation and therapeutic vulnerabilities in colorectal cancer.Mol Biol Rep2026https://conductscience.org/library/papers/42758364PubMed
42597529GSG2 promotes aerobic glycolysis and colorectal cancer progression via the MDM2-p53 axis.Am J Cancer Res2026https://conductscience.org/library/papers/42597529PubMed
42591618High SRD5A2 expression is associated with poor prognosis and promotes tumor cell progression in colorectal cancer.Transl Cancer Res2026https://conductscience.org/library/papers/42591618PubMed
42465030RPS2 and EEF1B2 are associated with glycolysis-related malignant phenotypes in COAD.Am J Cancer Res2026https://conductscience.org/library/papers/42465030PubMed
42418117METTL3-YTHDF1-driven m6A enhancement of MYC signaling orchestrates DNA repair and metabolic reprogramming to promote chemoresistance in colorectal cancer.Mol Cell Biochem2026https://conductscience.org/library/papers/42418117PubMed
42400616Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42400616PubMed
42346101Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet-Microbiota Axis.Cells2026https://conductscience.org/library/papers/42346101PubMed
42106773Integrative single-cell and spatial multi-Omics analyses identify NETs-driven colon cancer subtypes with distinct metabolic features and prognostic implications.J Transl Med2026https://conductscience.org/library/papers/42106773PubMed
42076017Diagnostic Potential of Exosomes in Colorectal Cancer: Current Advances and Future Perspectives.Molecules2026https://conductscience.org/library/papers/42076017PubMed
41923267FBXO39 promotes LDHA-mediated aerobic glycolysis and colorectal cancer progression by p53 degradation.J Transl Med2026https://conductscience.org/library/papers/41923267PubMed
41803973Fusobacterium nucleatum promotes tumor progression driven by histone lactylation through increasing GLUT1 expression in colorectal cancer.J Transl Med2026https://conductscience.org/library/papers/41803973PubMed
41771836Splice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function.Cell Death Dis2026https://conductscience.org/library/papers/41771836PubMed
41688960A TXNIP-driven bioluminescent reporter for high-throughput discovery of glycolytic inhibitors against renal cell carcinoma.BMC Biotechnol2026https://conductscience.org/library/papers/41688960PubMed
41586238Impact of metabolic risk factors on colorectal cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.Front Nutr2025https://conductscience.org/library/papers/41586238PubMed
41465299The Role of Gut Microbiota in Colorectal Cancer Pathogenesis: A Comprehensive Literature Review.Int J Mol Sci2025https://conductscience.org/library/papers/41465299PubMed
41415548Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies.Front Oncol2025https://conductscience.org/library/papers/41415548PubMed
41387212Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells.Int J Cancer2026https://conductscience.org/library/papers/41387212PubMed
41327072The metabolic crossroads: glycolysis in cancer and neurodegeneration.BMC Neurol2025https://conductscience.org/library/papers/41327072PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39405607

GET https://conductscience.org/api/papers/v1/39405607/references?page=2